Net Income (Quarterly) Chart

View Net Income (Quarterly) for ETST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Net Income (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 0.7157M
March 31, 2026 1.288M
December 31, 2025 0.9104M
September 30, 2025 0.9459M
June 30, 2025 0.4567M
March 31, 2025 1.173M
December 31, 2024 0.2064M
September 30, 2024 0.7984M
June 30, 2024 1.076M
March 31, 2024 0.2318M
December 31, 2023 0.2254M
September 30, 2023 0.4446M
June 30, 2023 -0.0356M
March 31, 2023 -0.2355M
December 31, 2022 0.0985M
September 30, 2022 -0.0737M
June 30, 2022 -0.1547M
March 31, 2022 -0.0307M
December 31, 2021 -0.115M
September 30, 2021 3.341M
June 30, 2021 -0.0224M
March 31, 2021 -0.2169M
December 31, 2020 -0.1108M
September 30, 2020 -0.168M
June 30, 2020 -3.888M
Date Value
March 31, 2020 -0.2621M
December 31, 2019 -0.1809M
September 30, 2019 -0.2503M
June 30, 2019 -0.5067M
March 31, 2019 -0.5653M
December 31, 2018 -0.5214M
September 30, 2018 -0.6093M
June 30, 2018 -0.5193M
March 31, 2018 -0.5501M
December 31, 2017 -0.5382M
September 30, 2017 -0.2485M
June 30, 2017 -0.3408M
March 31, 2017 -0.7359M
December 31, 2016 -0.0824M
September 30, 2016 -0.1655M
June 30, 2016 -0.1155M
March 31, 2016 -0.1115M
December 31, 2015 -0.2676M
September 30, 2015 -0.6418M
June 30, 2015 -0.4056M
March 31, 2015 11.80M
December 31, 2014 -7.598M
September 30, 2014 -0.24M
June 30, 2014 -0.2218M
March 31, 2014 -12.51M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Resonate Blends, Inc. -0.9669M
Breakthrough Chemistry, Inc. -1.083M
Kaya Holdings, Inc. -8.592M
Cardiac Biotech Solutions, Inc. -0.1372M
Endexx Corp. -1.288M